Claire M. Lucas, Robert J. Harris, Athina Giannoudis, Andrea Davies, Katy Knight, Sarah J. Watmough, Lihui Wang and Richard E. Clark (2009) “Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript”, Haematologica. Pavia, Italy, 94(10), pp. 1362-1367. doi: 10.3324/haematol.2009.009134.